Alcon, a division of Novartis, recently introduced in Europe its new AcrySof® IQ PanOptix® Toric presbyopia- and astigmatism-correcting intraocular lens (IOL) for patients with pre-existing corneal astigmatism undergoing cataract surgery.
According to Alcon, the new lens received CE Mark status in November 2016 and was recently launched in Spain, Portugal and Chile.
The AcrySof IQ PanOptix Toric IOL was reportedly designed for primary implantation in the capsular bag of the posterior chamber of the human eye for the visual correction of aphakia and pre-existing corneal astigmatism secondary to removal of a cataractous lens or clear lens. It is indicated for adult patients with and without presbyopia undergoing cataract surgery who desire near, intermediate and distance vision with increased spectacle independence. And it reportedly uses the same trifocal optic as the AcrySof IQ PanOptix IOL on the front surface of the lens, and combines it with the astigmatic correction features of a toric IOL on the back surface.
Click here to read the full press release.
Like what you read? Follow OphthalmologyWeb to keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.